Clinical Trial Update: Safety Study of Avian Flu Vaccine [Phase 1]

View source ↗

Summary

Phase 1 safety study of an avian influenza (H5N1) vaccine conducted by NIAID has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Influenza Virus Subtype H5n1

Drugs mentioned

• Avian influenza vaccine

Snippet

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) | Conditions: Influenza A Virus, H5N1 Subtype, Influenza A Virus | Phase 1 | Status: COMPLETED